NCT06574711

Brief Summary

The purpose of this study was to assess the effect of the daily intake of yogurts enhanced with Sacha Inchi oil and hybrid palm tree oil on human plasma lipids related to cardiovascular risk factors

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 22, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 28, 2024

Completed
Last Updated

August 28, 2024

Status Verified

August 1, 2024

Enrollment Period

8 months

First QC Date

August 14, 2024

Last Update Submit

August 24, 2024

Conditions

Keywords

PUFAcardiovascular risklipid profilehealthy volunteersyogurtsacha inchi oilinterspecific hybrid palm oil

Outcome Measures

Primary Outcomes (7)

  • Change in plasma levels of total cholesterol

    Measure in plasma (mmol/l)

    Baseline, 1 month, 2 months and 3 months

  • Change in plasma levels of LDL-cholesterol

    Measure in plasma (mmol/l)

    Baseline, 1 month, 2 months and 3 months

  • Change in plasma levels of HDL-cholesterol

    Measure in plasma (mmol/l)

    Baseline, 1 month, 2 months and 3 months

  • Change in plasma levels of triacylglycerols

    Measure in plasma (mmol/l)

    Baseline, 1 month, 2 months and 3 months

  • Change in plasma levels of Apolipoprotein A1 (ApoA1)

    Measure in plasma (g/l)

    Baseline, 1 month, 2 months and 3 months

  • Change in plasma levels of Apolipoprotein B (ApoB)

    Measure in plasma (g/l)

    Baseline, 1 month, 2 months and 3 months

  • ApoB/ApoA1 ratio

    prognostic predictor of a 10 year cardiovascular event

    Baseline, 1 month, 2 months and 3 months

Study Arms (3)

Control yogurt

PLACEBO COMPARATOR

Participants consumed a 200 g bottle of plain Yogurt with 3.5% unreplaced fat orally, daily, for 90 days

Other: Control yogurt

Sacha inchi oil yogurt

EXPERIMENTAL

Participants consumed a 200 g bottle of Yogurt with 3.5% replacement of dairy fat for Sacha inchi oil, orally, daily, for 90 days

Other: Sacha inchi oil yogurt

Hybrid palm oil yogurt

EXPERIMENTAL

Participants consumed a 200 g bottle of Yogurt with 3.5% replacement of dairy fat for Hybrid Palm Oil, daily, for 90 days

Other: Hybrid palm oil yogurt

Interventions

Sacha inchi oil was incorporated into a nonfat yogurt acting as a source of linolenic acid

Sacha inchi oil yogurt

Interspecific hybrid palm oil was incorporated into a nonfat yogurt as a source of bioactive compounds

Hybrid palm oil yogurt

Conventional full-fat yogurt

Control yogurt

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Normal total cholesterol (≤200mg/dl) levels
  • Have a yogurt consumption habit of at least three times a week
  • Maximum level of moderate physical activity
  • Body mass index (BMI) of ≤29.9kg/m2
  • Serum triacylglycerols below 400mg/dl

You may not qualify if:

  • Presence of chronic disease (Arterial hypertension, Diabetes Mellitus, among others)
  • A history of illicit drug use and/or chronic alcohol use, active smoking
  • A well-established allergy to red palm olein and/or milk and its derivatives
  • Consumption of nutritional supplements (antioxidants, omega 3, fiber, phytosterols)
  • Pregnancy or lactation
  • Having menopause
  • High consumption of nuts, flaxseed, chia, and sesame seeds

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pontificia Universidad Javeriana

Bogotá, 110231, Colombia

Location

MeSH Terms

Conditions

Cardiovascular DiseasesFood Preferences

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Lilia Y Cortés, PhD

    Pontificia Universidad Javeriana

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Forty-seven subjects were randomized and assigned to one of the three intervention groups supplemented daily with 200g of: Sacha Inchi Oil (SIO)-containing yogurt (Group-A), Hybrid palm oil (HPO)-containing yogurt (Group-B), and plain yogurt (Group-C).
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: A pilot randomized; double-blind, parallel-controlled pragmatic trial was performed
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 14, 2024

First Posted

August 28, 2024

Study Start

March 22, 2022

Primary Completion

November 30, 2022

Study Completion

May 7, 2024

Last Updated

August 28, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Due to the informed consent, no individual data can be shared; however, the results will be shared in a scientific publication

Locations